Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2016-11-18 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
关于获得《药品GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a Drug GMP Certificate from a regulatory authority. It includes details about the certificate, its validity, and the impact on the company's operations and financials. The document is short (794 characters) and serves as an official announcement rather than a detailed report or financial statement. It does not contain financial data, audit information, or management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about compliance and certification.
2016-11-18 Chinese
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds. It details the company's purchase of financial products, amounts, dates, and expected yields. The document is relatively short (1476 characters) and focuses on updates about financing activities related to cash management and investment products. There is no indication of full financial statements, audit opinions, or comprehensive financial reports. The content aligns with updates on company financing activities rather than a full report or regulatory filing. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2016-11-18 Chinese
关于取得医疗器械注册证书的补充公告
Regulatory Filings Classification · 95% confidence The document is a supplementary announcement regarding the acquisition of medical device registration certificates by the company. It provides detailed information about the R&D investment, similar products, and the impact of these certificates on the company. The document is an announcement of regulatory approval and related information, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is a regulatory announcement related to product registration and compliance with regulatory requirements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-11-18 Chinese
关于取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (629 characters) about the company receiving a medical device registration certificate from a regulatory authority. It describes the product details, registration number, validity, and expected use, and discusses the potential market impact. There is no financial data, no mention of financial results, no detailed report or presentation, and no voting or management changes. The document is an official regulatory announcement about a product certification, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2016-11-16 Chinese
关于取得换发《药品生产许可证》的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement from Zhengzhou Antu Bioengineering Co., Ltd. regarding the obtaining of a renewed Drug Production License issued by the Henan Food and Drug Administration. It includes details about the license number, validity period, and the scope of production. The document explicitly states it is an announcement and does not contain financial statements, management discussion, or detailed financial data. It is not a report but a regulatory announcement about a license renewal. The document length is only 572 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-11-14 Chinese
使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle raised funds. It details the purchase and redemption of wealth management products, including amounts, dates, and expected yields. The document is short (1205 characters) and focuses on updates about the company's use of idle raised funds for cash management, not a financial report or audit. It does not contain financial statements or detailed financial analysis. It is an announcement about financing activities related to the use of raised funds. Therefore, it fits best under Capital/Financing Update (CAP).
2016-11-14 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.